Choshi, Japan

Yoshida Ko

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Yamasa Corporation. Active years: 2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yoshida Ko in Pharmaceutical Raw Materials

Introduction

Yoshida Ko is a notable inventor based in Choshi, Japan. He has made significant contributions to the field of pharmaceutical raw materials through his innovative work. His research focuses on developing easier-to-handle crystals that enhance the shelf life of pharmaceutical products.

Latest Patents

Yoshida Ko holds a patent for a hydrate crystal of 3',3′-cGAMP. This invention addresses the limitations of commonly known lyophilized products, which require a lyophilizer for manufacturing. The need for such specialized equipment restricts mass production capabilities. His invention provides a solution by offering a crystal form that is less hygroscopic than existing powders, making it easier to handle for various applications.

Career Highlights

Yoshida Ko is associated with Yamasa Corporation, where he continues to innovate in the field of pharmaceutical materials. His work has the potential to revolutionize the way pharmaceutical raw materials are produced and handled. With a focus on practicality and efficiency, he aims to simplify the production process for better accessibility.

Collaborations

Yoshida Ko collaborates with talented coworkers such as Ishige Kazuya and Takamatsu Misaki. Their combined expertise contributes to the advancement of innovative solutions in their field.

Conclusion

Yoshida Ko's contributions to the development of hydrate crystals for pharmaceutical applications highlight his innovative spirit and dedication to improving production processes. His work not only addresses existing challenges but also paves the way for future advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…